You are here

Home » Content

Kemil iliği nakillerinde aşılama protokolleri

VACCINATION STRATEGIES IN PATIENTS WITH BONE MARROW TRANSPLANTATION

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1998

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Effective prevention against infectious diseases is more useful and life-saving measure than to treat them. Vaccination seems more effective preventive approach in decreasing the incidence of some important infectious diseases in immunocompromised patients most likely healthy individuals. Bone marrow transplantation presents prototypic clinical manifestations for immunocompromised patient. Also, vaccination of BMT donors to protect the recipient against a variety of infections is an appealing approach. In this paper, vaccination strategies have been reviewed and evaluated to give most useful and cost-effective approach in patients (and their donors) with bone marrow transplantation.
Bookmark/Search this post with
Abstract (Original Language): 
Infeksiyon hastalıklarından aşı ile korunma, onların tedavi edilmeleri ile karşılaştırılamayacak kadar avantajları olan bir yaklaşımdır. Bu durum immun sistemi baskılanmış olan hastalarda daha da önem kazanır. Bu çalışmada, immun sistemi baskılanmış olan hastalar için güzel bir örnek olan kemik iliği nakli yapılmış olan hastaların ve onların vericilerinin bazı infeksiyonlara karşı aşılanmaları ile korunmaları yönünde yapılan çalışmalar değerlendirilerek ortak bir yaklaşım ortaya konulmaya çalışılmıştır
FULL TEXT (PDF): 
PDF icon arastirmax-kemil-iligi-nakillerinde-asilama-protokolleri.pdf
  • 2-3
196-204
  • Turkish

REFERENCES

References: 

I. Centers for Disease Control and Prevention . Recommendations of the Immunization Practices Advisory Committee (ACIP): General recommendations on immunization. MMWR. 1994;43(RR-1) .
2 . Lum LG, Munn NA, Schanfield MS, Storb R. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 1986;67:582-7.
3. Lum LG, Seigneuret MC, Storb R. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. J Clin Immunol
1986;6:389-96
4. Wimperis JZ, Brenner MK, Prentice HG, et al. Transfer of a functioning humoral immune system in transNantation of T-lymphocyte-depleted bone marrow Lancet 1986;1:339-43
5. Baumgartner C, Morell A, Hirt A, et al. Humoral immune function in pediatric patients treated with autologous bone marrow transplantation for Bcellnon-Hodgkin's lymphoma. The influence of ex vivo marrow decontamination with anti-Y 29/55 monoclonal antibody and complement. Blood 1988;71:1211-17.
6. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989;159:610-5.
7. Ljungman P, Wiklund Hammarsten M, Duraj V, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect
Dis 1990;162:496-500.
8. Rege K, Mehta J, Treleaven J, et al. Fatal pneumococcal infections following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:903-6.
9. Aucouturier P, Barra A, Intrator L, et al. Long lasting IgG subclass and antibacterial polysaccbaride antibody deficiency after allogeneic bone marrow transplantation. Blood 1987;70:779-85.
10. Lossos IS, Breuer R, Or R, at al. Bacterial pneumonia in recipients of bone marrow transplantation. Afive-year prospective study. Transplantation
1995;60:672-8.
II. Ljungman P, Cordonnier C, De Bock R, et al. Immunizations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995;15:455-60.
12. Somani 3, Larson RA. Re-immunization after allogeneic bone marrow transplantation. Am J Med 1995;98:389-98.
13. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80.
14. Symann M, Bosly A, Gisselbrecht C, Brice P, Franks C. Immune reconstitution after bone-marrow transplantation. Cancer Treat Rev 1989;16 (Suppl A):15-9.
15. Atkinson K. Reconstruction of the hemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5:209-26.
16. Kelsey SM, Lowdell MW, Newland AC. IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation. Clin Exp Immunol 1990;80:409-12.
17. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992;9:395-408.
18. Storek 3, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. Bcell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993;12:387-98.
19. Storek S; Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-25.
20. Roberts MM, To LB, Gillis D, et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993;12:469-75.
21. Ottinger HD, Beelen DW; Scheulen B, Schaefer UW; Grosse-Wilde H. Improved immune reconstitution after allo-transplantation of peripheral blood stem cells instead of bone marrow. Blood 1996;88:2775-9.
22. Singhal S, Powles R, Treleaven 3, Long S, Rowland A, Mehta J. Comparison of cell yields in a double-blind randomized study of allogeneic marrow vs. b1ood stem cell transplantation. Br J Haematol 1996;93 (Suppl
1):37.
23. Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995;11:95-105.
24. Gratama JW, Verdonck LF, van der Linden JA, et al. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation. Transplantation 1986;41:719-24.
25. Li Volti S, Mauro L, Di Gregorio F, et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant
1994;14:225-7.
Turgut Özal Tıp Merkezi Dergisi 5(2,3):1998
203
Vaccination strategies in patients with bone marrow transplantation
26. Barra A, Cordonnier C, Preziosi MP, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J
Infect Dis 1992;166:1021-8.
27. Guinan EC, Molrine DC, Antin JH, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation
1994;57:677-84.
28. Molrine DC, Guinan EC, Antin JH, et al. Donor immunization with Haemophilus influenzae type b (Hib)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996;87:3012-8.
29. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
Hepatology 1993;18:246-52.
30. Nagler A, Ilan Y, Adler R, et al. Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplant 1995;15:475-8.
31. Ilan Y, Nagler A, Adler R, Tur Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology 1993;104:1818-21.
32. Ilan Y, Nagler A, Shouval D, et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors. Clin Exp Immunol 1994;97:299-302
33. Potter MN, Foot AB, Oakhill A. Influenza A and the virus associated hemophagocytic syndrome: cluster of three cases in children with acute leukemia. J Clin Pathol 1991;44:297-9.
34. Whimbey E, Eiting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow
Transplant 1994;13:437-40.
35. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11:1-5.
36. Pauksen K, Duraj V; Ljungman P, et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992;9:427-32.
37. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994;84:657-63.
38. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the
Americas. Evolving strategies. JAMA 1996;275:1311-12.
39. Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and anti-thymocyte globulin treatment. Blood 1981;58:360-8.
40. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch
Intern Med 1983;143:1735-7.
41. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992;88:512-9.
42. Avanzini MA, Carra AM, Maccario R, et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995;15:137-44.
43. Hammarstrom V, Pauksen K, Azinge J, Oberg U, Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence ofgraft-versus-host reaction. Support Care Cancer 1993;1:195-9.
44. de Quadros CA, Andrus JK, Olive JM, Carrasco P. Strategies for poliomyelitis eradication in developing countries. Public Health Rev 1993-
94;21:65-81.
45. Anonymous. Progress towards global poliomyelitis eradication, 1985¬1994. MMWR 1995;44:273-5,281.
46. Engelhard D, Handsher R, Naparstek E, et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow
Transplant 1991;8:295-300.
47. Ljungman P, Duraj M Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant
1991;7:89-93.
48. Pauksen K, Hammarstrom V, Ljungman P, et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994;18:547-52.
49. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-52.
50. Wimperis JZ, Brenner MK, Prentice HG, Thompson EJ, Hoffbrand AV. B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987;138:2445-50.
51. Gerritsen EJ, van Tol MJ, van't Veer MB, et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Blood 1994;84:4374-82.
52. Shepherd DM, Noelle RJ. The lackofmemoryB cells in immune bone marrow. Transplantation 1991;52:97-100.
53. Wimperis JZ, Gottlieb D, Duncombe AS, Heslop HE, Prentice HG, Brenner MK. Requirements for the adoptive transfer of antibody responses to a priming antigen in man. J Immunol 1990;144:541-7.
54. Gottlieb DJ, Cryz SJ Jr, Furer B, et al. Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.
Blood 1990;76:2470-5.
55. Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Sem Resp Infect 1995;10:199-208.
56. Heslop HE, Ng JY, Li C, Smith CA, Loftin SK, Krance RA, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes. Nature Med
1996;2:551-5.
57. Barnes RA. Immunotherapy and immunoprophylaxis in bone marrow transplantation. J Hosp Infect 1995;30(Suppl):223-31.
58. Khouri IF, Ippoliti C, Gajewski J, Przepiorka D, Champlin RE. Neutropenias following allogeneic bone marrow transplantation: response to therapy with increased dose intravenous immunoglobulin.
Am J Hematol 1996;52:313-5.
59. Dal-Re R, Gil A, Gonzalez A, Lasheras L. Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative clinical trial in adults. J Clin
Pharmacol 1995;35:420-5.

Thank you for copying data from http://www.arastirmax.com